Cargando…
Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916296/ https://www.ncbi.nlm.nih.gov/pubmed/27152845 http://dx.doi.org/10.1038/bcj.2016.27 |
| _version_ | 1782438806563061760 |
|---|---|
| author | Chen, Z Wang, W Cortes, J E Liu, E Miranda, R N Zhao, C Yuan, J Lu, X Yang, W Ameri, M D Kantarjian, H M Medeiros, L J Hu, S |
| author_facet | Chen, Z Wang, W Cortes, J E Liu, E Miranda, R N Zhao, C Yuan, J Lu, X Yang, W Ameri, M D Kantarjian, H M Medeiros, L J Hu, S |
| author_sort | Chen, Z |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4916296 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49162962016-06-30 Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy Chen, Z Wang, W Cortes, J E Liu, E Miranda, R N Zhao, C Yuan, J Lu, X Yang, W Ameri, M D Kantarjian, H M Medeiros, L J Hu, S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-05 2016-05-06 /pmc/articles/PMC4916296/ /pubmed/27152845 http://dx.doi.org/10.1038/bcj.2016.27 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Chen, Z Wang, W Cortes, J E Liu, E Miranda, R N Zhao, C Yuan, J Lu, X Yang, W Ameri, M D Kantarjian, H M Medeiros, L J Hu, S Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| title | Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| title_full | Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| title_fullStr | Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| title_full_unstemmed | Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| title_short | Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| title_sort | differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916296/ https://www.ncbi.nlm.nih.gov/pubmed/27152845 http://dx.doi.org/10.1038/bcj.2016.27 |
| work_keys_str_mv | AT chenz differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT wangw differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT cortesje differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT liue differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT mirandarn differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT zhaoc differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT yuanj differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT lux differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT yangw differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT amerimd differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT kantarjianhm differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT medeiroslj differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy AT hus differentialclinicalandprognosticimpactofmyeloidsarcomavsmedullarymyeloidblastphaseofchronicmyelogenousleukemiaintheeraoftyrosinekinaseinhibitortherapy |